Clinical trial
Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing…
NCT00430079 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00430079 |
|---|---|
| Title | Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma |
| Official title | Assessment of Hypoxia in Malignant Gliomas Using EF5 |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma, Adult Ependymoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma, Adult Myxopapillary Ependymoma and 4 more |
| Intervention type | Drug, Other, Procedure |
| Interventions | etanidazole, conventional surgery, pharmacological study, laboratory biomarker analysis |
| Enrollment | 48 |
| Start date | Jul 1, 2001 |
| Primary completion | Sep 1, 2007 |
| First posted | Feb 1, 2007 |
| Last update posted | Jan 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: